Across TCGA patient cohorts, KRT18P22 RNA expression is significantly associated with the protein abundance of many other proteins, with 8,542 significant associations in total. LSCC shows the largest number of these associations.

The most reproducible KRT18P22-associated proteins across cancer lineages are ARHGAP9, PTPRC, and MYO1F. Each is linked with KRT18P22 in more than 5 cancer types. Because this analysis shows association rather than direction, both KRT18P22-to-partner and partner-to-KRT18P22 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (KRT18P22→partner) and Y-score (partner→KRT18P22) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
COAD	ARHGAP9 →	+0.473	+0.168	<.001	<.001	3	6
BRCA	PTPRC →	+0.565	+0.162	<.001	<.001	3	6
GBM	MYO1F →	+0.490	+0.274	.002	<.001	3	6
OV	SAMHD1 →	+0.517	+0.172	<.001	.005	3	6
COAD	CORO1A →	+0.434	+0.152	<.001	<.001	3	6
GBM	FMNL1 →	+0.465	+0.245	.001	.002	3	6

Each partner links to its Q-omics profile. Showing the 6 strongest of 8,542 associations by consensus.

Exploration

KRT18P22 survival (RNA) · tumor vs normal (RNA) · all KRT18P22 data types